Brought to you by 
Merck sells out its stake in Du Pont Merck Pharmaceutical
13 Jul 1999
Executive Summary
Merck will exercise its option to sell DuPont its half interest in DuPont Merck Pharmaceutical, the company they formed in 1990 as a joint venture. DuPont will pay $2.6bn (25 times earnings, agreed fair market value).
Deal Industry
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Joint Venture
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Merck sells out its stake in Du Pont Merck Pharmaceutical
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice